Vance G. Fowler
Duke University
490 Papers
1.6K Citations
Vance G. Fowler is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Bacteremia. The author has an hindex of 95, co-authored 414 publications. Previous affiliations of Vance G. Fowler include Statens Serum Institut & Purdue University.
Chat about Author
Papers
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
TL;DR: This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of S. aureus as a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections.
4.4K
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Jennifer S. Li,Daniel J. Sexton,Nathan Mick,Richard E. Nettles,Vance G. Fowler,Thomas J. Ryan,Thomas M. Bashore,G. R. Corey +7 more
TL;DR: Modifications of the Duke criteria for the diagnosis of infective endocarditis are proposed, including that positive Q-fever serology should be changed to a major criterion and the minor criterion "echocardiogram consistent with IE but not meeting major criterion" should be eliminated.
3.9K
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
David R. Murdoch,G. Ralph Corey,Bruno Hoen,José M. Miró,Vance G. Fowler,Arnold S. Bayer,Adolf W. Karchmer,Lars Olaison,Paul A. Pappas,Philippe Moreillon,Stephen T. Chambers,Vivian H. Chu,Vicenç Falcó,David Holland,Philip Jones,John L Klein,Nigel Raymond,Kerry Read,Marie Francoise Tripodi,Riccardo Utili,Andrew Wang,Christopher W. Woods,Christopher H. Cabell +22 more
TL;DR: In the early 21st century, IE is more often an acute disease, characterized by a high rate of S aureus infection, and Mortality remains relatively high.
2.2K
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Larry M. Baddour,Walter R. Wilson,Arnold S. Bayer,Vance G. Fowler,Imad M. Tleyjeh,Michael J. Rybak,Bruno Baršić,Peter B. Lockhart,Michael H. Gewitz,Matthew E. Levison,Ann F. Bolger,James M. Steckelberg,Robert S. Baltimore,Anne M. Fink,Patrick T. O'Gara,Kathryn A. Taubert +15 more
TL;DR: The recommendations provided in this document are intended to assist in the management of this uncommon but potentially deadly infection and must be used to support and not supplant decisions in individual patient management.
2.1K
Infective Endocarditis Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Larry M. Baddour,Walter R. Wilson,Arnold S. Bayer,Vance G. Fowler,Ann F. Bolger,Matthew E. Levison,Patricia Ferrieri,Michael A. Gerber,Lloyd Y. Tani,Michael H. Gewitz,David C. Tong,James M. Steckelberg,Robert S. Baltimore,Stanford T. Shulman,Jane C. Burns,Donald A. Falace,Jane W. Newburger,Thomas J. Pallasch,Masato Takahashi,Kathryn A. Taubert +19 more
TL;DR: The third iteration of the Infective Endocarditis "treatment" document developed by the American Heart Association under the auspices of the Committee on Rheumatic fever, endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young was presented in this article.
1.6K